Title: "Development and Implementation of Innovative Auditory Training Methods and Verification of These Training Methods"

September 7, 2017 updated by: Annamary (Ann) Peterson, Mayo Clinic
The purpose of this study is to determine if aural rehabilitation adds measurable benefit and participant satisfaction to a cochlear implant recipient's overall treatment. Also, the study is designed to compare the efficacy of a commercially available aural rehabilitation program (LACE) and an electronic program which takes advantage of a traditional form of auditory training (NOOK) for cochlear implant users.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The primary objective of this study is to determine if aural rehabilitation adds measurable benefit and participant satisfaction to a cochlear implant recipient's overall treatment.

The secondary objective of this study is to compare the efficacy of a commercially available aural rehabilitation program (LACE) and an electronic program which takes advantage of a traditional form of auditory training (NOOK) for cochlear implant users.

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Criteria for Inclusion:

  • Willingness to participate
  • Ability to provide informed written consent
  • Willingness to follow study protocol
  • Eighteen years or older at the time of signing the consent form
  • Cochlear implant experience for 12 months or greater
  • Spoken English as the first language
  • Access to a home computer which meets the minimal requirements to run appropriate program or the ability to use an electronic reader depending on which group the participant is assigned to.
  • Reports being comfortable using a computer if in the LACE group

Criteria for Exclusion:

  • Unable or unwillingness to sign informed written consent
  • Unable or unwillingness to follow study protocol
  • Non-English speaking or English as a second language
  • No access to a computer if assigned to the LACE study group
  • Reports not being comfortable using a computer if assigned to the LACE study group.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Active Comparator: LACE ( Listening And Communication Enhancement )
use the commercially available auditory training program which is administered by computer as daily lessons.
commercially available LACE program which is administered by computer as daily lessons. The participants will do this program for one month
Active Comparator: NOOK (Electronic reader)
will use an electronic reader (NOOK device) to do speech tracking
will use an electronic reader (Barnes and Noble - NOOK device) to do speech tracking.will do this activity for approximately one hour per day for five days out of seven for a total of four weeks. The speech tracking activity will involve reading approximately two books within the one month time frame. The participants will listen to the book while reading an unabridged book in printed form.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Word recognition
Time Frame: baseline to 6 months
Word recognition will be measured using the Consonant Nucleus Consonant (CNC) Test, a 50 word open set test.
baseline to 6 months
Signal-to-noise ratio
Time Frame: baseline to 6 months
The signal to noise ratio will be measured using the Bamford-Kowal-Bench (BKB) test.
baseline to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent of speech comprehension
Time Frame: baseline to 6 months
Percent of speech comprehension will be measured by the AzBio Sentence Lists, which were created at Arizona State University and evaluate speech understanding.
baseline to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Annamary Peterson, Mayo Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

November 27, 2012

First Submitted That Met QC Criteria

November 27, 2012

First Posted (Estimate)

November 29, 2012

Study Record Updates

Last Update Posted (Actual)

September 8, 2017

Last Update Submitted That Met QC Criteria

September 7, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 12-007641

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cochlear Implant

Clinical Trials on LACE

Subscribe